Home Featured Page 126

Featured

Latest

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

Small Pharma Reports Fiscal Third Quarter 2023 Highlights

Hebrew University’ Yissum and Israeli Biotech Clearmind Medicine’s Psychedelic-Derived Obesity Treatment...

Small Pharma Reports Positive Top-line Results from Phase IIa Trial of...

GH Research Provides Business Updates and Highlights Key Upcoming Milestones

Small Pharma To Announce Results of SPL026 Phase IIa Trial for...

Diamond Therapeutics Announces Health Canada Approval of Phase 2 Clinical Trial...

Panel: Three Psychedelics Companies that Raised in 2022

PT383 – Identity, Rage, Culture, and Venture Capital

Panel: Psychedelic VCs Reflect on 2022

Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer

EDITOR PICKS

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

ShroomskiCon 2026

Small Pharma Reports Fiscal Third Quarter 2023 Highlights

Hebrew University’ Yissum and Israeli Biotech Clearmind Medicine’s Psychedelic-Derived Obesity Treatment...

Small Pharma Reports Positive Top-line Results from Phase IIa Trial of...

GH Research Provides Business Updates and Highlights Key Upcoming Milestones

Small Pharma To Announce Results of SPL026 Phase IIa Trial for...

Diamond Therapeutics Announces Health Canada Approval of Phase 2 Clinical Trial...

Panel: Three Psychedelics Companies that Raised in 2022

PT383 – Identity, Rage, Culture, and Venture Capital

Panel: Psychedelic VCs Reflect on 2022

Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer

EDITOR PICKS

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY